baber/WOPTO huggingface dataset:
Patent NZ-568332-A (NZ)
Title: Process for the preparation of ferri-succinylcasein
Inventor: KLOTZ JURGEN
IPC: A61K38/17
Filed: 2006-11-28
Abstract: A process for the preparation of ferro-succinylcasein is disclosed which comprises the following steps: (a) reacting casein with at least one succinylation agent to form an aqueous suspension of succinylcasein, and (b) reacting the aqueous suspension of succinylcasein obtained in step (a) with at least one iron salt to form ferro-succinylcasein the process may further comprise the following steps:(c) dissolving said ferro-succinylcasein by the addition of at least one base, to form an aqueous composition comprising dissolved ferro-succinylcasein, (d) separating insoluble matter from said aqueous composition comprising dissolved ferro-succinylcasein to obtain an aqueous solution of ferrosuccinylcasein, (e) precipitating ferro-succinylcasein from said aqueous solution by adding at least one acid, and recovering the ferro-succinylcasein obtained, and (f) drying said ferro-succinylcasein obtained, or further processing the wet ferro-succinylcasein obtained directly into a pharmaceutical formulation.
Patent NZ-569249-A (NZ)
Title: System and method for a programmable multimedia controller
Inventor: MODONNA ROBERT P
IPC: H04N21/436
Filed: 2006-12-20
Abstract: A multimedia controller comprises one or more audio input modules coupled to an audio crosspoint switch; one or more video input modules coupled to a video crosspoint switch; one or more audio output modules coupled to the audio crosspoint switch; one or more video output modules coupled to the video crosspoint switch and a general purpose computer. Each of the audio input modules has a connection for one or more audio signal sources and each of the audio input modules are configured to convert audio signals of varying formats to a predetermined audio signal format. Each of the video input modules has a connection for one or more video signal sources and each of the video input modules are configured to convert video signals of varying formats to a predetermined video signal format. Each of the audio output modules have a connection for one or more audio output devices and are configured to convert the predetermined audio signal format to a format compatible with a selected audio output device. Each of the video output modules have a connection for one or more video output devices and each of the video output modules are configured to convert the predetermined video signal format to a format compatible with a selected video output device; and The general purpose computer is coupled in communicating relationship with the audio and video crosspoint switches and is for controlling the switches such that audio signal sources are switched through the audio crosspoint switch to selected audio output devices and video signal sources are switched through the video crosspoint switch to selected video output devices in accordance with one or more application programs executed by the general purpose computer. The general purpose computer further is configured to overlay at least one of video, graphics, and text originating from the general purpose computer at one or more selected regions within frames of at least some of the video signals from the video signal sources that are switched through the video crosspoint switch to the selected video output devices, before the video signals are output to the selected video output devices, the one or more selected regions chosen on a frame-by-frame basis.
Patent NZ-569530-A (NZ)
Title: Nuclear reprogramming factor
Inventor: YAMANAKA SHINYA
IPC: A61P25/16
Filed: 2006-12-06
Abstract: Disclosed is A nuclear reprogramming factor for a somatic cell, which comprises: an Oct family gene or gene product thereof, a KIf family gene or gene product thereof, and a Myc family gene or gene product thereof. Also disclosed is a method for preparing an induced pluripotent stem cell by nuclear reprogramming of a somatic cell, which comprises a step of contacting the said nuclear reprogramming factor with the somatic cell.
Patent NZ-575167-A (NZ)
Title: Pyrido (2, 3-d) pyrimidin0ne compounds and their use as pi3 inhibitors
Inventor: CHENG HENGMIAO
IPC: A61K31/519
Filed: 2007-09-03
Abstract: Disclosed are pyrido (2,3-D) pyrimidinone compounds of Formula (I), Formula (II) or Formula (III) wherein R1 is H or optionally substituted (C1-6)alkyl and wherein the rest of the substituents are disclosed within the specification. Also disclosed is the use of a compound of Formula (I), (II) or (III) in the manufacture of a medicament for the treatment of abnormal cell growth in a mammal such as cancer or for inhibiting PI3-Kalpha enzymatic activity.
Patent NZ-575275-A (NZ)
Title: Assembly for and method of grazing
Inventor: VAN DEN BERG KAREL
IPC: A01K3/00
Filed: 2009-03-03
Abstract: A moveable assembly for delineating a cattle grazing area comprises at least three spaced apart holders 2, 3a, 3b, 3c directly or indirectly connected by wires 4a, 4b, 4c, 4d which can be moved by the holders. At least two holders are self-propelled and at least one holder is also a milking station. The assembly has the advantage being able to provide fresh grazing to the cattle while not having to move them to and back from a milking station located elsewhere.
Patent NZ-579297-A (NZ)
Title: Combination therapy comprising an il-23 antagonist and a cytokine antagonist for treatment of immune disorders
Inventor: CUA DANIEL J
IPC: A61P37/00
Filed: 2008-02-26
Abstract: Disclosed is a bispecific antibody, or antigen binding fragment thereof, that specifically binds to IL-23R and CD161.
Patent NZ-582600-A (NZ)
Title: Electric fence energiser with automatic control circuit capable of detecting human contact
Inventor: HAMM VALERY
IPC: H05C3/00
Filed: 2008-06-20
Abstract: Disclosed is an electric fence energiser including a measurement and control circuit (8) comprising: means for the periodic measurement of at least one electric parameter characteristic of the instantaneous impedance at the terminals of the energiser, using a sufficiently short period so that the measurement can be repeated multiple times during the pulse; comparison means for comparing the results of the measurement of the at least one parameter to reference values; and control means which can instantly alter the characteristics of the current pulse so that it does not pose a danger to people in the event of a deviation between the measurement results and the reference values, which deviation may indicate that a person has come into contact with the fence (6).
Patent NZ-587776-A (NZ)
Title: Therapy of autoimmune disease in a patient with an inadequate response to a TNF-alpha inhibitor using anti-CD20 antibody
Inventor: BENYUNES MARK C
IPC: C07K16/28
Filed: 2004-04-06
Abstract: The use of rituximab for treating rheumatoid arthritis to result in a beneficial clinical response in a patient who experiences an inadequate response to a TNF-alpha inhibitor. The rituximab is administered in two doses each containing 1000mg of the antibody. The first dose is administered on day 1 of treatment and the second dose is administered on day 15. A beneficial clinical response is an ARC50 response, an ARC70 response or no erosive progression at weeks 24 and beyond. The rituximab is to be administered to patients also receiving methotrexate treatment.
Patent NZ-587777-A (NZ)
Title: An attachable stand for a stringed musical instrument and methods for its use and manufacture
Inventor: MCALISTER DARRYL
IPC: G10G5/00
Filed: 2010-09-03
Abstract: An attachment for a stringed musical instrument is disclosed. The instrument (12) includes a body with a standing end. The attachment (1) includes a mating surface configured to engage with the standing end of the instrument, and a support surface. The horizontal cross- section mating and support surfaces are approximately equal to, or less than, the ground space that is taken up by the musical instrument when it is placed on its standing end. The width of the support surface is approximately equal to the depth of the body of the musical instrument.
Patent NZ-588721-A (NZ)
Title: Substituted dihydropyrazolones as inhibitors of hif-prolyl-4-hydroxylases
Inventor: JESKE MARIO
IPC: A61K31/506
Filed: 2009-04-11
Abstract: Disclosed herein are substituted dihydropyrazolone-pyrimidine compounds of formula (I), wherein X represents N or CH, R1 represents hydrogen or cyano, R2 represents piperazin-1-yl, where piperazin-1-yl is substituted by one substituent, where the substituent is selected from the group consisting of C3-C6-cycloalkyl; processes for their preparation, compositions comprising said compound. Said compounds are useful for treatment and/or prophylaxis of cardiovascular diseases, 5 cardiac insufficiency, anaemia, chronic kidney diseases and renal insufficiency. Particularly preferred compounds included: · 2-[6-(4-Cyclobutylpiperazin-1-yl)pyrimidin-4-yl]-4-(1H-1,2,3-triazol-1-yl)-1,2-dihydro-3H-pyrazol-3-one · 2-[6-(4-Cyclobutylpiperazin-1-yl)pyrimidin-4-yl]-4-(1H-1,2,3-triazol-1-yl)-1,2-dihydro-3H-pyrazol-3-one · 1-{ 2-[6-(4-Cyclobutylpiperazin-1-yl)pyrimidin-4-yl]-3-oxo-2,3-dihydro-1H-pyrazol-4-yl} -1H-imidazole-4-carbonitrile · 1-{ 2-[6-(4-Cyclobutylpiperazin-1-yl)pyrimidin-4-yl]-3-oxo-2,3-dihydro-1H-pyrazol-4-yl} -1H-imidazole-4-carbonitrile
Patent NZ-591295-A (NZ)
Title: Electrical heater with a resistive neutral plane
Inventor: DUBEY ASHISH
IPC: H05B3/20
Filed: 2009-09-16
Abstract: A heating system (20) in the form of a multi-layer panel (22) comprises a first electrically insulating layer (24); a second electrically insulating layer (26); a third electrically insulating layer (28); a first electrically conductive resistive layer (30) sandwiched between the first and second electrically insulating layers; and a second electrically conductive resistive layer (32) sandwiched between the second and third electrically insulating layers. The first electrically conductive resistive layer had a first electrical connection and a second electrical connection. The first and second electrical connections are electrically connected to each other only by electrically resistive material of the first electrically conductive resistive layer extending between the first and second electrical connections. The second electrically conductive resistive layer has a first electrical connection being electrically connected with the first electrical connection of the first electrically conductive resistive layer; and the second electrically conductive resistive layer is electrically isolated from the second electrical connection of the first electrically conductive resistive layer by the second electrically insulating layer.
Patent NZ-594945-A (NZ)
Title: Human binding molecules having killing activity against enterococci and staphylococcus aureus and uses thereof
Inventor: DE KRUIF CORNELIS ADRIAAN
IPC: A61K39/116
Filed: 2007-06-05
Abstract: Disclosed is a human monoclonal antibody as defined in the complete specification. The disclosed antibody is characterised in that it has opsonic phagocytic killing activity against at least one strain of each of at least two different Enterococcus species and against at least one strain of Staphylococcus aureus. Also disclosed is the use of said antibody in the manufacture of a medicament for the diagnosis, prophylaxis, treatment, or combination thereof, of an enterococcal infection and/or a staphylococcal infection.
Patent NZ-595474-A (NZ)
Title: Fastener tip coating chemistry
Inventor: LAT GERONIMO E
IPC: F16B15/00
Filed: 2010-04-15
Abstract: 595474 Disclosed herein is a coating fastener comprising a fastener having a tip, and a coating on the fastener, at least at the tip, the coating formulated from a resin modified with at least two different friction reducing components; a coating for a fastener; and a strip of collated fasteners. Additionally disclosed is wherein the resin is an acrylic resin and the coating is a formulation of an amine salt of modified acrylic copolymer, an ammonia salt of modified styrene acrylic polymers, water, one or more of glycol ethers, surfactants, a pigment, ammonium hydroxide and a rust inhibitor. Additionally disclosed is wherein one of the friction reducing components is silicone and the other is graphite.
Patent NZ-596032-A (NZ)
Title: Human binding molecules capable of neutralizing influenza virus h3n2 and uses thereof
Inventor: THROSBY MARK
IPC: A61K39/42
Filed: 2010-05-06
Abstract: NZ 596032 Disclosed is an isolated human binding molecule capable of specifically recognising and binding to an epitope in influenza haemagglutinin protein (HA), having neutralising activity against influenza viruses comprising HA of the H3 subtype, and having cross neutralising activity against at least an influenza virus comprising HA of the H7 subtype, and/or an influenza virus comprising HA of the H10 subtype, wherein the binding molecule binds to an epitope comprising the amino acid at position 19, 25, 27, 33 and/or 34 of the HA2 polypeptide of the H3 HA protein.
Patent NZ-596226-A (NZ)
Title: Antitumor combination including cabazitaxel and capecitabine
Inventor: MAGHERINI EMMANUELLE
IPC: A61K31/7068
Filed: 2010-05-06
Abstract: 596226 Disclosed herein is a pharmaceutical antitumor combination including cabazitaxel and capecitabine, wherein both of said antitumor agents may be in the form of a base, in the form of a pharmaceutically acceptable acid salt or in the form of a hydrate or solvate, intended for the treatment of metastatic breast cancer in patients progressing after a previous treatment with anthracyclines and taxanes.
Patent NZ-599079-A (NZ)
Title: Method, system and device of phase identification using a smart meter
Inventor: PAMULAPARTHY BALAKRISHNA
IPC: G01R22/00
Filed: 2012-03-28
Abstract: Disclosed is a meter (106) comprised of one or more switches (204) and metering components (208, 210). The one or more switches (204) are used to connect a device (102) to at least a first phase of a poly-phase electrical system. The metering components (208, 210) are used to meter at least the first phase (A) of the poly-phase electrical system that the device (102) is connected to for electrical consumption information. The meter (106) also comprises a memory, at least one network interface and a processor. The processor is operably connected with the one or more switches (204), the metering components (208, 210), the memory and the at least one network interface. The processor is configured to store in the memory a first phase identifier for the first phase (A) of the poly-phase electrical system that the device (102) is connected to. The processor is also configured to control the one or more switches (204) to switch the device (102) such that the device (102) is connected to at least a second phase (B) of the poly-phase electrical system such that the metering components (208, 210) meter at least the second phase (B) of the poly-phase electrical system. The processor is configured to then store a second phase identifier for the second phase (B) of the poly-phase electrical system that the device (102) is connected to in the memory associated with the meter (106).
Patent NZ-599578-A (NZ)
Title: Creation of mosaics using poyhedral beads made from a water soluble resin
Inventor: KAMIYAMA KEI
IPC: C08F2/18
Filed: 2012-04-24
Abstract: 599578 Disclosed is a mosaic toy with water fusible beads. The toy comprises a polyhedral particulate bead made of a transparent and water soluble resin. The polyhedral particulate bead has a shape of a polyhedron with 12 to 62 faces, which is selected from a group consisting of a regular dodecahedron, a regular icosahedron, a rhombic triacontahedron and a truncated regular polyhedron obtained by cutting vertices of a regular polyhedron, and a dual thereof. The particle diameter of the particulate bead is 3 mm to 6 mm and are coloured transparent, and the set of the particulate beads includes beads of different colours.
Patent NZ-599755-A (NZ)
Title: Compositions and methods of using proislet peptides and analogs thereof
Inventor: LEVETAN CLARESA S
IPC: A61K38/22
Filed: 2008-08-29
Abstract: Discloses a proislet peptide comprising an optimization modification, wherein said optimization modification is a C-terminal cysteine residue, wherein said peptide is selected from: modified HIP1,HIP2,HIP3, human REG3A/REG3G, human REGlA/REGIB, human REG4, hamster INGAP, hamster REG2, rodent REG3G, rat REGl, rat PAP/REG3B, rat PAP3, mouse REG l/REG2/REG3A/REG3B /REG3G/REG3S/REG4 peptides and bovine PTP peptide. Further discloses a optimization modification that is N-terminal acetyl group and a C terminal cysteine residue. Further disclosed is the use of disclosed peptides in the manufacture of a pharmaceutical composition for treating a pathology associated with impaired pancreatic function (e.g. diabetes).
Patent NZ-602014-A (NZ)
Title: Retaining wall system
Inventor: THURLOW PHIL
IPC: E04B2/42
Filed: 2012-08-23
Abstract: 602014 Disclosed is a retaining wall system comprising multiple first blocks (1) and second blocks laid in courses to form a retaining wall. Each of the first blocks (1) comprises opposed front (4) and rear (6) walls, the blocks (1) being open from above and below and from each end to receive an infill material. The infill material fills up the open ends of adjacent blocks (1) to lock the blocks (1) within in the same course together. The first blocks (1) are the principal blocks used to form the wall with the first blocks (1) being laid in successive courses with the blocks (1) of each upper course being stacked upon those of a lower course. Each first block (1) has location means (8b) to locate a block of an upper course stacked thereon to permit variable displacement of the upper block relative to the lower block in a forwards/rear direction. The upper block is displaceable relative to the lower block between a position in which the front face (4) of the wall of the upper block is substantially flush with that of the lower block and a position in which the front face (4) of the front waIl of the upper block is set back from that of the lower block. The location means define limits for such movement while permitting the upper block to be set in any selected position between those limits. The second blocks (not shown) are corner/end blocks to be laid at the end of a course of the first blocks (1) to close off the open end of an adjacent first block and/or to commence a course of a second wall joined to the first at right angles thereto.
Patent NZ-603439-A (NZ)
Title: Improvements in and relating to load transfer
Inventor: SINGH KALVIN JIT
IPC: A01B59/04
Filed: 2012-11-06
Abstract: 603439 Disclosed is a load sensing and lift cylinder adjusting system for a three-point linkage arrangement (1002) on a tractor (1000). The system includes a control system and load setting system, a load sensing system and a load adjusting system. The load setting system is configured to allow a desired load to be pre-set for lift cylinder(s) (1004) of the three point linkage (1002) when first connected to a towed implement (1001) and prior to commencing a work operation with the implement (1001). Once the load setting system has pre-set the load, the load sensing system is informed of a pre-set load being selected and then monitors the load on the lift cylinder(s) (1004). If the load drops from the pre-set load a signal is sent to the load adjusting system which diverts oil from a pressurised oil supply to the lift cylinder(s) (1004) to maintain the pre-set load. If the pre-set load is exceeded a signal is sent to the load adjusting system which diverts oil from the lift cylinder(s) (1004) back to the tractor hydraulic oil supply.
Patent NZ-610331-A (NZ)
Title: Viral polymerase inhibitors
Inventor: HALIM ROSLIANA
IPC: A61K31/416
Filed: 2011-10-20
Abstract: Provided are indazole derivative compounds, of general formula (I), wherein the variables are as defined in the specification. Examples of the compounds include 2-(4-bromophenyl)-5-cyclopropyl-N-methyl-6-[(methylsulfonyl)amino]-2H-indazole-3-carboxamide and 2-(4-bromophenyl)-5-cyclopropyl-6-{ [(difluoromethyl)sulfonyl](ethyl)amino} -N-methyl-2H-indazole-3-carboxamide. The compounds are inhibitors of the viral polymerase NS5B. Further provided are methods for preparing the compounds, pharmaceutical compositions comprising them and methods of treating hepatitis C virus (HCV) using the compounds.
Patent NZ-617053-A (NZ)
Title: Motorised conveyor for moving a flow of harvest from a fruit harvesting machine
Inventor: LE NEVE DANIEL H A M
IPC: B65G13/02
Filed: 2012-05-04
Abstract: A motorised conveyor (1) for moving a flow of harvest coming from a fruit harvesting machine is disclosed. The conveyor comprises a plurality of rollers (3) spaced longitudinally, the rollers being driven in rotation to move the flow of harvest on the rollers in a longitudinal direction (L1) between upstream (4) and downstream (5) transverse axes. Each roller (3) has a surface of revolution comprising grooves that extend transversely and continuously over its entire length, so as to enable transverse routing of the flow of harvest while it is being conveyed. The invention also concerns a sorting device comprising such a conveyor, a cleaning system comprising such a sorting device, and a fruit harvesting machine comprising such a sorting device or such a cleaning system.
Patent NZ-630400-A (NZ)
Title: A moment frame connector, moment frame connector assembly and moment frame
Inventor: DONALD ANDREW SUTHERLAND
IPC: E04C3/02
Filed: 2014-05-16
Abstract: A moment frame connector 1 arranged to provide a connection between a C-section or Z-section beam of a moment frame and a column of the moment frame, comprises a first portion 3 arranged to be connected to the column, a second portion 7 arranged to be connected to a flange of the C-section or Z-section beam, and a third portion 11 arranged to be connected to a web of the C-section or Z-section beam. Each portion is provided with at least two mounting apertures on each portion 5, 9, 13 arranged to receive a respective fixing to connect that portion to the column or beam.
Patent NZ-706448-A (NZ)
Title: Method and system for wave energy conversion
Inventor: PRUDELL JOSEPH
IPC: F03B13/20
Filed: 2013-09-30
Abstract: An apparatus for converting wave energy and method for using the apparatus, the apparatus comprising a buoyant nacelle having a central longitudinal axis; a first spar mated to the nacelle; a second spar mated to the nacelle; a first float positioned to rotate about the central longitudinal axis within a radial span bounded by an outer surface of the nacelle and a radially distal end of the first float, wherein the first float is operatively coupled to a first power take off; and a second float positioned to rotate about the longitudinal axis within a radial span bounded by a radially distal end of the first float and a radially distal end of the second float, wherein the second float is operatively coupled to a second power take off or the first power take off; wherein the first float and the second float are free to rotate 360 degrees about the central longitudinal axis.
Patent NZ-710691-A (NZ)
Title: Methods of treating iron deficiency with soluble ferric pyrophosphate
Inventor: GUPTA AJAY
IPC: A61P7/06
Filed: 2014-02-01
Abstract: The invention provides for methods of treating iron deficiency and methods of reducing or eliminating the dose of erythropoiesis stimulating agent for increasing or maintaining hemoglobin levels in the target range in a subject suffering from anemia comprising administering soluble ferric pyrophosphate in an amount effective to maintain or increase Hgb levels in the subject.